CON — Concentra Group Holdings Parent, Inc. Stock Price, Chart & AI Report

Positive Oct 14, 2026 • 14:40 UTC Zacks Investment Research • Na

CON vs. MEDP: Which Stock Should Value Investors Buy Now?

In a comparison of two Medical Services stocks, Concentra Group (CON) emerges as the superior value option compared to Medpace (MEDP). CON holds a Zacks Rank of #2 (Buy) with improving earnings outlook and more attractive valuation metrics, including a forward P/E of 22.74 versus MEDP's 34.77, and a PEG ratio of 1.37 versus 2.72. CON also received a Value grade of B compared to MEDP's D grade.

CON MEDP value investing medical services valuation metrics P/E ratio PEG ratio earnings estimates

Sentiment note

CON has a Zacks Rank #2 (Buy), improving earnings outlook, lower forward P/E ratio (22.74), lower PEG ratio (1.37), lower P/B ratio (9.91), and a Value grade of B, making it the more attractive value investment option.

Positive Oct 7, 2026 • 15:08 UTC Zacks Investment Research • Na

Encompass Health Expands Rehab Footprint With New Maine Hospital

Encompass Health Corporation (EHC) opened its first wholly owned hospital in Maine with 50 inpatient rehabilitation beds. Q2 2026 discharges rose 5.6% year-over-year, driven by new capacity and 2.8% same-store growth. EHC opened three hospitals in the first half of 2026 and plans to open eight new hospitals throughout the year, reflecting its strategy to expand capacity in favorable markets.

EHC CON PAHC WGS inpatient rehabilitation hospital expansion capacity growth Maine market

Sentiment note

Carries Zacks Rank #1 (Strong Buy) with two upward earnings revisions in the past 30 days. Beat earnings estimates in all trailing four quarters with 16.3% average surprise, and consensus revenue estimate suggests 8.7% year-over-year growth.

Positive Sep 15, 2026 • 13:15 UTC Zacks Investment Research • Zacks.Com

Concentra Group Holdings Parent, Inc. (CON) Hits Fresh High: Is There Still Room to Run?

Concentra Group (CON) has reached a new 52-week high of $36.05, gaining 82% year-to-date and outperforming its sector. The company maintains a Zacks Rank #1 (Strong Buy) with consistent earnings beat records and a VGM Score of B. However, valuation metrics show the stock trades at a premium to peers (21.7X forward P/E vs. 17X industry average), raising questions about further upside potential.

CON PGNY Concentra Group earnings surprise 52-week high valuation premium Zacks Rank #1 Medical Services industry

Sentiment note

Strong fundamentals with consistent earnings beats (4 consecutive quarters), Zacks Rank #1 (Strong Buy), 82% YTD gain, and positive earnings revision trend. However, sentiment is tempered by premium valuation metrics relative to peers.

Positive Sep 11, 2026 • 15:40 UTC Zacks Investment Research • Na

CON vs. MEDP: Which Stock Is the Better Value Option?

A comparison of two Medical Services sector stocks reveals that Concentra Group (CON) is more attractive to value investors than Medpace (MEDP). CON has a stronger Zacks Rank (#1 vs #2), lower valuation multiples (forward P/E of 20.95 vs 33.25, PEG ratio of 1.26 vs 2.60, and P/B ratio of 9.04 vs 37.52), and a better Value grade (B vs D), making it the superior option for value-focused investors.

CON MEDP value investing valuation metrics P/E ratio PEG ratio Zacks Rank Medical Services sector

Sentiment note

CON demonstrates stronger fundamentals for value investors with a Zacks Rank #1 (Strong Buy), lower forward P/E ratio (20.95), lower PEG ratio (1.26), lower P/B ratio (9.04), and a Value grade of B, indicating more attractive valuation metrics and better earnings estimate revision activity.

Neutral Aug 8, 2025 • 01:29 UTC The Motley Fool • Jesterai

Concentra (CON) Q2 Revenue Jumps 15%

Concentra Group Parent reported Q2 2025 revenue of $550.8 million, a 15.2% year-over-year increase, driven by acquisitions and organic growth. Despite beating revenue estimates, earnings per share missed expectations, and profitability was pressured by higher expenses.

CON occupational health earnings revenue growth acquisitions healthcare services

Sentiment note

Mixed financial performance with strong revenue growth (15.2%) offset by lower earnings per share, rising expenses, and margin pressures. Management raised full-year guidance, indicating confidence in future performance.

Positive Nov 6, 2024 • 21:30 UTC Benzinga • Prnewswire

Select Medical Holdings Corporation Announces Declaration of a Special Stock Distribution to Spin-Off Concentra

Select Medical Holdings Corporation announced a special stock distribution to spin-off its Concentra subsidiary, which is the largest provider of occupational health services in the United States.

SEM CON Select Medical Holdings Corporation Concentra spin-off occupational health services

Sentiment note

Concentra is being spun-off as the largest provider of occupational health services in the United States, indicating it is a strong and valuable business unit within Select Medical Holdings Corporation.

Negative Oct 7, 2024 • 18:02 UTC Benzinga • Piero Cingari, Benzinga Staff Writer

Stocks Slip As Oil Prices Climb, 10-Year Yields Cross 4%; Energy Sector Outperforms: What's Driving Markets Monday?

Stocks opened lower as geopolitical tensions in the Middle East escalated, driving up oil prices and Treasury yields. The energy sector outperformed, while other sectors declined. Concerns over potential Israeli retaliation against Iran and the ongoing war in Gaza weighed on the market.

TLT SMCI EG STZ stocks oil prices Treasury yields energy sector

Sentiment note

Concentra Group Holding Parent Inc. (CON) fell 4.6% after Bank of America downgraded several healthcare stocks.